Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
Clinical Outcomes
100%
Overall Survival
100%
Corticosteroids
100%
Immune-related Adverse Events
100%
IrAE
100%
PD-1 Inhibitor
100%
Corticosteroid Treatment
66%
No Significant Difference
33%
High Dose
33%
Cox Proportional Hazards Model
33%
Antitumor Effect
33%
Poor Prognostic Factors
33%
High-dose Corticosteroids
33%
Steroid Treatment
33%
High-dose Steroids
33%
Time-dependent Covariates
33%
Low-dose Steroids
33%
Severe Immune-related Adverse Events
33%
Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Immunotherapy
100%
Immune-Related Adverse Events
100%
Programmed Cell Death
75%
Overall Survival
75%
Drug Megadose
75%
Corticosteroid Therapy
50%
Proportional Hazards Model
25%
Prognostic Factor
25%
Low Drug Dose
25%
Steroid Treatment
25%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
100%
Immunotherapy
100%
Non Small Cell Lung Cancer
100%
Overall Survival
75%
Programmed Cell Death
75%
Steroid Treatment
25%
Immunology and Microbiology
Immunotherapy
100%
Overall Survival
100%
Programmed Cell Death 1
100%
Drug Megadose
100%
Low Drug Dose
33%
Biochemistry, Genetics and Molecular Biology
Overall Survival
100%
Drug Megadose
100%
Programmed Cell Death 1
100%
Low Drug Dose
33%